Advertisement

Topics

Companies Related to "Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer" [Most Relevant Company Matches] - Page: 3 RSS

15:33 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Addition Paclitaxel High Dose Combination Chemotherapy Treating Patients" Companies 51–75 of 9,100+

Relevant

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...


Speedel

Speedel is a biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases. Our lead product candidate SPP100 (Aliskiren), the first-in-class renin inhibitor,...

VisionGate, Inc.

VisionGate, Inc. is led by Dr. Alan Nelson, physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. VisionGate offers the first automated 3D cell imaging platform, the Cell-CT, which computes high-resolution 3D biosignatures f...


Novacea

We are a biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for the treatment of cancer. We currently have two clinical-stage oncology product candidates. Our lead product candidate, Asentar™ (DN-101), is in a Phase 3 clinical trial for the treatment of androgen-independent prostate cancer, or AIPC, also known as hormone-refractory prostate cancer. ...

Nuvelo, Inc.

Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. Nuvelo's development pipeline includes NU172, a direct thrombin inhibitor in Phase 1 development for use as a potential short-acting anticoagulant during medical or surgical proce...

Carbylan BioSurgery, Inc.

Carbylan (www.carbylan.com) was founded in 2005 to develop and market medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat...

VisionGate Inc.

VisionGate, Inc. is led by Dr. Alan Nelson, physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. VisionGate produces the first automated 3D cell imaging platform, the Cell-CT, which computes high-resolution 3D biosignatures...

ADD dental facility

Dr Nick Mohindra first became interested in this field when he was treating patients who were suffering from what is known as TMD syndrome. This is a group of symptoms including sore facial muscles, tense neck and shoulders, or back and head pains, often caused by jaw relationship problems. It occurred to him that the technique he was using to treat these patients could also benefit denture patien...

Glide Pharma

Glide Pharma is a specialty pharmaceutical company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-house and partnered programmes based on its proprietary needle-free solid dose injector, the Glide SDI(R).

Saddleback Memorial Medical Center

With campuses in Laguna Hills and San Clemente, Saddleback Memorial provides exceptional medical expertise across a range of treatment areas including cancer, stroke, and cardiac care. Innovations like robotic surgery, low dose CT, and dedicated breast MRI set us apart. In addition, The Women’s Hospital at Saddleback Memorial – Laguna Hills offer...

Entropin

Entropin, Inc. (NASDAQ: ETOP) is a specialty pharmaceutical development company focused on commercializing Esterom®, a revolutionary new topical drug with the potential to replace other current therapeutics for treating impaired physical function resulting from painful soft tissue injuries and diseases -- such as tendonitis, bursitis and lower back sprain. The Esterom® market is currently served...

Cancer Supportive Care Programs

The mission of the Cancer Supportive Care Web Site (CSCW) is to provide multidisciplinary information and services for cancer patients and their families/friends This website provides online support for patients undergoing surgery, radiation therapy, chemotherapy, hormonal therapy or immunotherapy. El Cuidado Sustento Del Cáncer de Ernest H. Rosenbaum, MD y Isadora R. Rosenbaum, MA La Declaració...

Sinexus, Inc.

Sinexus, Inc. (http://www.sinexusinc.com) is a development-stage medical device company that is pioneering novel therapies for Ear, Nose & Throat (ENT) physicians to utilize in providing improved treatment for their patients. Sinexus' initial focus is treating patients with Chronic Rhinosinusitis, a debilitating chronic condition that affects one out of seven adults in the United States.

Cytheris SA

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.  These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transp...

Horizon Pharma, Inc.

Horizon Pharma, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and chronic inflammation. Horizon's product portfolio includes innovative therapies in early- and late-stage development that are designed to improve the efficacy, safety and quality of life for patients with chronic pain and inflammati...

US Bioscience Incorporated

US Bioscience, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for patients with cancer and allied diseases such as AIDS. Currently, three of the Company's products are marketed by US Bioscience and its commercial partners: Ethyol® (amifostine) A selective cytoprotective agent for reduction of toxicities associated with cancer chemotherapy. Hexalen...

Sensorion

Spun off from Inserm (the French institute of health and medical research) in 2009, Sensorion is a biotech that specializes in the treatment of pathologies of the inner ear such as acute vertigo, tinnitus and hearing loss. Backed by its pharmaceutical R&D experience and a comprehensive technology platform, Sensorion is developing three drug candidate progr...

GenVec

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent-protected technology platform to deliver genes that produce medically beneficial proteins directly at the site of disease. TNFerade™ represents a novel approach to treating cancer in combination with rad...

Diagnovus, LLC

Founded in 2011 and based in Nashville, Tenn., Diagnovus is a specialized molecular diagnostic company focused on delivering personalized information and services to physicians treating patients suffering from underserved, aggressive and lesser-known diseases. Its mission is to improve the health of patients and the quality of treatment decisions through e...

Merz Pharma Group Merz Pharma Group

The Merz Pharma Group’s focus is on drugs for treating neurological and psychiatric conditions and the group holds a leading position in the field of Alzheimer’s research. With memantine, the Merz Pharma Group has developed the first active ingredient in the world for treating moderate to severe cases of Alzheimer’s. Worldwide, memantine is the sec...

SharedClarity

SharedClarity is a unique joint effort between health care systems and UnitedHealthcare to use data from tens of millions of patients to study the long-term effectiveness of high-technology medical devices that have a high impact on patients. SharedClarity will use the results of the studies to select the best devices for patients and negotiate affordable ...

Angiotech Pharmaceuticals Incorporated

Angiotech Pharmaceuticals, Inc. is dedicated to the development of medical device coatings and treatments for chronic inflammatory diseases through the reformulation of the anticancer drug paclitaxel. If you're excited by the challenge of Advancing the Potential of Proven Medicines.

Genomic Health, Inc.

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the global development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX® breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as w...

MediSafe Inc. and AppScript

MediSafe™ is a leading mobile medication management platform that reminds patients to take their medications via smartphones and tablets, serving to improve medication adherence rates and curb the growing annual health care costs globally. The personalized application – already downloaded by more than 1.4 million users worldwide – alerts fam...

SolaranRx, Inc.

SolaranRx, Inc. is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for treating metastatic melanoma. SolaranRx seeks to improve treatment and patientsâ€...


More From BioPortfolio on "Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks